Rapha Capital Management Announces First Managed Venture Fund Focused On Investment In Early-Stage Biotech Startups
Rapha Capital Management Announces First Managed Venture Fund Focused On Investment In Early-Stage Biotech Startups
04/15/21, 12:36 PM
Location
Rapha Capital Management ("RCM") (https://www.raphacap.com), an investment management firm focused in life sciences, today announced the launch of its first managed venture capital fund, Rapha Capital BioVentures Fund I, LP (the "RCBV Fund"), with a target raise of $100M and solely focused on investment in early-stage life science companies. The RCBV Fund builds on an investor base from Rapha Capital's previous thirteen special purpose investment vehicles, Rapha Capital Investment ("RCI") I – XIII that currently manages $25M in early-stage biotech investments since its inception in 2017. The RCBV Fund has capital commitments from this base of current Rapha investors.